4//SEC Filing
Hwang Larn 4
Accession 0001493152-18-005443
CIK 0000737207other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 9:40 PM ET
Size
11.4 KB
Accession
0001493152-18-005443
Insider Transaction Report
Form 4
Hwang Larn
Chief Scientific Officer
Transactions
- Conversion
Series E Convertible Preferred Stock
2018-04-16$5000.00/sh+10.44$52,200→ 10.44 totalExercise: $0.50From: 2018-04-16→ common stock (104,400 underlying) - Conversion
Warrants to Purchase Common Stock
2018-04-16+78,300→ 78,300 totalExercise: $0.55From: 2018-04-16→ common stock (78,300 underlying) - Conversion
5% Convertible Promissory Note
2018-04-16Exercise: $5000.00From: 2018-04-16→ Preferred Stock / Warrants
Footnotes (5)
- [F1]On April 16, 2018, the reporting person and the issuer amended the convertible promissory note in the principal amount of $50,000 that the issuer issued to the reporting person in June 2017 so that the unpaid principal amount thereof, together with accrued but unpaid interest thereon, would be converted into 10.44 shares of the issuer's Series E Convertible Preferred Stock and warrants to purchase up to 78,300 shares of the issuer's common stock upon the closing of the private placement of Series E Preferred Stock and common stock purchase warrants on April 16, 2018 (the "Offering"). As a result of such conversion, the note has been satisfied in full and is no longer outstanding.
- [F2]Each outstanding share of Series E Preferred Stock shall be converted into common stock on the earliest to occur of: (i) any date more than 30 trading days after the closing of the Offering that the closing price of the common stock on each of the 30 days immediately prior to such conversion exceeds $5.00; (ii) the three year anniversary of the closing of the Offering; and (iii) the date on which the holders of a majority of the outstanding shares of Series E Preferred Stock elect to convert all of the outstanding shares of Series E Preferred Stock.
- [F3]The warrants expire on the five year anniversary of the closing of the offering.
- [F4]N/A
- [F5]The note converted into 10.44 shares of Series E Convertible Preferred Stock and warrants to purchase 78,300 shares of common stock.
Documents
Issuer
Marina Biotech, Inc.
CIK 0000737207
Entity typeother
Related Parties
1- filerCIK 0001697480
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 9:40 PM ET
- Size
- 11.4 KB